FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

703840003: Aflibercept (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3009274019 Aflibercept en Synonym Active Entire term case insensitive SNOMED CT core module
3009606010 Aflibercept (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aflibercept Is a Fusion protein true Inferred relationship Existential restriction modifier
Aflibercept Is a Substance with angiogenesis inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Aflibercept Has disposition Angiogenesis inhibitor true Inferred relationship Existential restriction modifier
Aflibercept Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Aflibercept Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier
Aflibercept Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing aflibercept Has active ingredient True Aflibercept Inferred relationship Existential restriction modifier 1
Product containing aflibercept in parenteral dose form (medicinal product form) Has active ingredient True Aflibercept Inferred relationship Existential restriction modifier 1
Aflibercept Has active ingredient True Aflibercept Inferred relationship Existential restriction modifier 1
Product containing only aflibercept in parenteral dose form (medicinal product form) Has active ingredient True Aflibercept Inferred relationship Existential restriction modifier 1
Product containing precisely aflibercept 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Aflibercept Inferred relationship Existential restriction modifier 1
Product containing precisely aflibercept 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Aflibercept Inferred relationship Existential restriction modifier 1
Aflibercept 100mg/4ml solution for infusion vials Has active ingredient False Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 200mg/8ml solution for infusion vials Has active ingredient False Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 4mg/100microlitres solution for injection vials Has active ingredient False Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Eylea 3.6mg/90microlitres solution for injection pre-filled syringes (Bayer Plc) Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes Has active ingredient False Aflibercept Inferred relationship Existential restriction modifier
Eylea 3.6mg/90microlitres solution for injection pre-filled syringes (Bayer Plc) 1 pre-filled disposable injection Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 4mg/100microlitres solution for injection vials 1 vial Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Eylea 4mg/100microlitres solution for injection vials (Bayer Plc) 1 vial Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Zaltrap 100mg/4ml concentrate for solution for infusion vials (Sanofi) 1 vial Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Zaltrap 200mg/8ml concentrate for solution for infusion vials (Sanofi) 1 vial Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 100mg/4ml solution for infusion vials Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 200mg/8ml solution for infusion vials Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 4mg/100microlitres solution for injection vials Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Eylea 4mg/100microlitres solution for injection vials (Bayer Plc) Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Zaltrap 100mg/4ml concentrate for solution for infusion vials (Sanofi) Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Zaltrap 200mg/8ml concentrate for solution for infusion vials (Sanofi) Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 200mg/8ml solution for infusion vials 1 vial Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier
Aflibercept 100mg/4ml solution for infusion vials 1 vial Has specific active ingredient True Aflibercept Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start